• Media type: E-Article
  • Title: Genome-wide specificity of highly efficient TALENs and CRISPR/Cas9 for T cell receptor modification
  • Contributor: Knipping, Friederike [VerfasserIn]; Petri, Karl [VerfasserIn]; Glimm, Hanno [VerfasserIn]; Kalle, Christof von [VerfasserIn]; Schmidt, Manfred [VerfasserIn]; Gabriel, Richard [VerfasserIn]
  • imprint: 12 February 2017
  • Published in: Molecular therapy. Methods & clinical development ; 4(2017), Seite 213-224
  • Language: English
  • DOI: 10.1016/j.omtm.2017.01.005
  • ISSN: 2329-0501
  • Identifier:
  • Origination:
  • Footnote: Available online 12 February 2017
  • Description: In T cells with transgenic high-avidity T cell receptors (TCRs), endogenous and transferred TCR chains compete for surface expression and may pair inappropriately, potentially causing autoimmunity. To knock out endogenous TCR expression, we assembled 12 transcription activator-like effector nucleases (TALENs) and five guide RNAs (gRNAs) from the clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated (Cas9) system. Using TALEN mRNA, TCR knockout was successful in up to 81% of T cells. Additionally, we were able to verify targeted gene addition of a GFP gene by homology-directed repair at the TALEN target site, using a donor suitable for replacement of the reporter transgene with therapeutic TCR chains. Remarkably, analysis of TALEN and CRISPR/Cas9 specificity using integrase-defective lentiviral vector capture revealed only one off-target site for one of the gRNAs and three off-target sites for both of the TALENs, indicating a high level of specificity. Collectively, our work shows highly efficient and specific nucleases for T cell engineering.
  • Access State: Open Access